Begonya Comin-Anduix
- Oncology top 1%
- Immunology top 1%
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Biomedical Engineering top 10%
- Co-authors
- Antoni RibasThomas G. GraeberRichard C. KoyaHelena Escuin-OrdinasThinle ChodonRoger S. LoBlanca Homet MorenoSiwen Hu‐Lieskovan
- Topics
- Immunotherapy and Immune Responses (19 papers)CAR-T cell therapy research (12 papers)Melanoma and MAPK Pathways (11 papers)
- Cited by
- ImmunologyOncologyMolecular Biology
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyNature Medicine
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Begonya Comin-Anduix
42 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 2.6k
- Immunology 2.1k
- Molecular Biology 1.7k
- Pulmonary and Respiratory Medicine 416
- Biomedical Engineering 405
Countries citing papers authored by Begonya Comin-Anduix
This map shows the geographic impact of Begonya Comin-Anduix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Begonya Comin-Anduix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Begonya Comin-Anduix more than expected).
Fields of papers citing papers by Begonya Comin-Anduix
This network shows the impact of papers produced by Begonya Comin-Anduix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Begonya Comin-Anduix. The network helps show where Begonya Comin-Anduix may publish in the future.
Co-authorship network of co-authors of Begonya Comin-Anduix
This figure shows the co-authorship network connecting the top 25 collaborators of Begonya Comin-Anduix. A scholar is included among the top collaborators of Begonya Comin-Anduix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Begonya Comin-Anduix. Begonya Comin-Anduix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 32 | |
| 2 | 1 | |
| 3 | 12 | |
| 4 | Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expressionbreakdown → | 1327 |
| 5 | 75 | |
| 6 | 285 | |
| 7 | 85 | |
| 8 | 112 | |
| 9 | 187 | |
| 10 | 60 | |
| 11 | 27 | |
| 12 | 78 | |
| 13 | 183 | |
| 14 | 288 | |
| 15 | 115 | |
| 16 | 84 | |
| 17 | 17 | |
| 18 | 35 | |
| 19 | 23 | |
| 20 | 89 |
About Begonya Comin-Anduix
Begonya Comin-Anduix is a scholar working on Immunology, Oncology and Toxicology, having authored 42 papers that have together received 4.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (19 papers), CAR-T cell therapy research (12 papers) and Melanoma and MAPK Pathways (11 papers). The work is most often cited by research in Immunology (2.1k citations), Oncology (2.6k citations) and Molecular Biology (1.7k citations). Begonya Comin-Anduix has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Antoni Ribas, Thomas G. Graeber, Richard C. Koya, Helena Escuin-Ordinas, Thinle Chodon, Roger S. Lo, Blanca Homet Moreno, Siwen Hu‐Lieskovan, Ángel García-Díaz and Willy Hugo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.